Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Feb 8, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how well an artificial intelligence (AI) system can help doctors find growths called adenomas during colonoscopies, which are tests used to look inside the colon. The trial aims to see if using this AI system, known as the GI Genius CADe, can increase the rate of adenomas detected compared to standard colonoscopy procedures. This could help improve the quality of care for patients undergoing these important screenings.

To be eligible for this trial, participants should be between the ages of 45 to 89 and scheduled for a routine colonoscopy for screening or monitoring purposes. Unfortunately, those with certain medical conditions, like emergency situations or specific bowel diseases, cannot participate. If you join the trial, you can expect to have the usual colonoscopy procedure, but with the added use of the AI system to assist your doctor. The study is currently recruiting participants, and all genders are welcome to take part.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • indication of undergoing a screening, surveillance, or diagnostic colonoscopy
• • Age 45-89 years
• Exclusion Criteria:
• • Patients undergoing emergency colonoscopy
• • Patients with a known familial polyposis syndrome or a known inflammatory bowel disease